Through a detailed exploration of SLC2A2 role in these processes, using a combination of molecular classification techniques and the zebrafish model [31], this research will enhance our understanding of the molecular mechanisms driving HCC progression and contribute to the development of targeted therapies that overcome the limitations of current treatment paradigms [5,32]. Here, SLC2A2 is linked to hepatocellular carcinoma.